Quantcast

Freeman Offers Hope Through Pinpoint Treatment - KOAM TV 7

Freeman Offers Hope Through Pinpoint Treatment

Updated:
Freeman Radiation Oncology Clinical Director Ben Blair demonstrates operation of TrueBeam linear accelerator during open house Freeman Radiation Oncology Clinical Director Ben Blair demonstrates operation of TrueBeam linear accelerator during open house
JOPLIN, MISSOURI -

JOPLIN, Mo. – Thanks to a generous gift from the Cornell-Beshore families, Freeman Health System Radiation Oncology recently opened at Freeman Hospital East to help patients with even the most difficult-to-treat tumors. Freeman’s newly acquired, top-of-class TrueBeam™ linear accelerator enables doctors to use a radically different approach to treating cancer with image-guided radiotherapy.

The TrueBeam system, from Varian Medical Systems, was engineered from the ground up to deliver powerful cancer treatments with pinpoint accuracy and precision. It uniquely integrates new imaging and motion management technologies within a sophisticated new architecture that makes it possible to deliver faster treatments while monitoring and compensating for tumor motion. This opens the door to new possibilities for the treatment of lung, breast, prostate, head and neck, and other cancers that are treatable with radiotherapy.

  • Freeman started treating patients with the new system in July 2015. Benefits to patients include:
  • Less time spent in treatment
  • Exposure to a lower dose of radiation
  • Improved outcomes through precise treatment

“TrueBeam is a real game-changer that will enable our physicians to treat even the most challenging cases with unprecedented speed and precision,” said Paula F. Baker, Freeman President and Chief Executive Officer. “With a broad spectrum of new capabilities, TrueBeam breaks the mold in just about every dimension, making it possible for us to offer faster, more targeted treatments to tumors, even as they move and change over time.

“With the linear accelerator, our physicians can target hard-to-reach cancers with pinpoint accuracy – in fact, our team can actually sculpt the radiation beam to the exact shape of the patient’s tumor,” Baker said. “This enables us to kill cancer cells while minimizing damage to surrounding, healthy tissue. It is one of the most powerful and precise cancer treatment options in the four-state area.”

Faster treatments

With dose delivery rates 40 to 140 percent higher than earlier generations of Varian technology, Freeman’s linear accelerator can complete a treatment commensurately faster. This makes it possible to offer greater patient comfort by shortening treatments and to improve precision by leaving less time for tumor motion during dose delivery. “Intelligent” automation further speeds treatments with an up to five-fold reduction in the number of steps needed for image guidance and dose delivery. 

Simple treatments that once took 15 minutes or more can be completed in less than two after the patient is in position. “The new system significantly reduces treatment time,” said Matthew Miller, DO, Freeman Cancer Institute Medical Director. “Patients will spend a whole lot less time lying still, immobilized on a hard surface.”

Enhanced precision

The precision of the TrueBeam system is measured in increments of less than a millimeter. This accuracy is made possible by the system’s sophisticated architecture, which synchronizes imaging, patient positioning, motion management, beam shaping and dose delivery, performing accuracy checks every 10 milliseconds throughout the entire treatment. Critical data points are measured continually as treatment progresses, ensuring the system maintains a true isocenter, or focal point, of treatment.

“This technology is important because cancer tumors do not stay in the exact same place after each radiation therapy session,” said Jeffrey Carrier, Freeman Chief Clinical Officer. “When a patient gains or loses weight or experiences other physical changes, organs can shift slightly. So – before each treatment – it’s imperative that physicians identify exactly where cancerous cells end and healthy cells begin.”

For lung and other tumors subject to respiratory motion, TrueBeam offers gated RapidArc® radiotherapy, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering the radiation dose during a continuous rotation around the patient. “During the last decade, lung cancer became the leading cause of cancer death for both men and women in the United States,” Dr. Miller said. “With this new linear accelerator, we can treat a moving lung tumor as if it were standing still. We expect this to make a meaningful difference for lung cancer patients in the area.”

Faster imaging at lower doses

TrueBeam imaging technology reduces the time needed to produce the three-dimensional images used to fine-tune tumor targeting by 60 percent. Additional functionality makes it possible to create these images while reducing the x-ray dose by 25 percent. “Imaging is an essential part of modern-day, targeted radiotherapy,” explained Dr. Miller. “This machine allows us to choose an imaging mode that minimizes the amount of radiation needed to generate an image – and that’s good for our patients.”

Leading the way in cancer care

Freeman Health System has provided comprehensive cancer care – including diagnosis, treatment, lifestyle management and some of the most advanced cancer-fighting tools and therapies available – since 2001. Freeman was able to launch its radiation oncology program thanks to a $3 million gift from the Cornell-Beshore families. In recognition of this generous donation, Freeman Cancer Institute recently became Cornell-Beshore Cancer Institute. It includes facilities on the campuses of both Freeman Hospital West and Freeman Hospital East.

“The Cornell and Beshore families are long-time champions of healthcare in our region, and it’s only fitting that the name honor their legacy,” said Baker. “Together we are dedicated to improving the future for cancer patients across the four-state area.”

  • NewsMore>>

  • Gas Prices Lowest in Midwest States and Good News for Travelers

    Gas Prices Lowest in Midwest States and Good News for Travelers

    Wednesday, November 21 2018 10:46 AM EST2018-11-21 15:46:43 GMT
    AAA reports gas prices for holiday travelers are virtually the same as last year and the lowest in the Midwest. We'll be talking to travelers about taking to the roads for the holiday and to law enforcement about how to stay safe on the highways. More >>
    AAA reports gas prices for holiday travelers are virtually the same as last year and the lowest in the Midwest. We'll be talking to travelers about taking to the roads for the holiday and to law enforcement about how to stay safe on the highways. More >>
  • KOAM MORNING NEWS TO KNOW 11-21

    KOAM MORNING NEWS TO KNOW 11-21

    Wednesday, November 21 2018 9:51 AM EST2018-11-21 14:51:26 GMT

    Area police prepare to keep drunk drivers off the road over Thanksgiving.  Plus all the news you need to know before you head out the door.

    More >>

    Area police prepare to keep drunk drivers off the road over Thanksgiving.  Plus all the news you need to know before you head out the door.

    More >>
  • Webb City Preps for Semifinal vs. Ladue

    Webb City Preps for Semifinal vs. Ladue

    Tuesday, November 20 2018 10:29 PM EST2018-11-21 03:29:09 GMT

    Webb City will host Ladue Horton Watkins in the Class 4 Semifinals Saturday, in a rematch of last year's state title game. 

    More >>

    Webb City will host Ladue Horton Watkins in the Class 4 Semifinals Saturday, in a rematch of last year's state title game. 

    More >>
Powered by Frankly

KOAM - Licensed to Pittsburg, Kansas
Send tips, ideas and press releases to: tips@koamtv.com
Send newsroom questions or comments to: comments@koamtv.com
Phone: (417) 624-0233 or (620) 231-0400
Web comments or questions: webmaster@koamtv.com
Newsroom Fax: (417) 624-3158

Powered by Frankly, Inc. All content © Copyright 2000 - 2018 KOAM. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.